BiotechTube
ArcScan

ArcScan

Golden, United States· Est.
arcscan.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ArcScan is a private medical device company that commercializes the Insight 100, a robotic ultrasound imaging system for ophthalmic surgical planning. Founded in 2005 (2007 per website) and based in Golden, Colorado, the company's technology addresses the 'Dark Zone' behind the iris, providing critical biometric data for procedures like ICL (Implantable Collamer Lens) sizing, corneal analysis, and intraocular lens selection. With installations in approximately 70 clinics globally, ArcScan is positioned as a tool for enhancing clinical confidence and surgical outcomes in the growing refractive and cataract surgery markets.

Ophthalmology

Technology Platform

Robotic, very high-frequency ultrasound (VHF-US) imaging system with a Swept Beam Liquid Interface for precise, repeatable visualization of the anterior eye segment, particularly structures behind the iris.

Funding History

2
Series AUndisclosed
SeedUndisclosed

Opportunities

The rapid growth of refractive surgery, particularly ICL procedures, creates a direct and expanding need for precise anterior chamber biometry.
The trend towards personalized, data-driven surgical planning in ophthalmology supports adoption of advanced imaging tools like the Insight 100.
The technology's unique ability to image the 'Dark Zone' behind the iris presents a defensible niche unmet by optical competitors.

Risk Factors

Competition from larger, well-funded medical device companies with broader portfolios and deeper sales channels.
Technological risk from potential future advancements in optical imaging that could reduce the unique advantage of ultrasound.
Market adoption risk, as growth is tied to surgeon acceptance of a new capital equipment purchase for specialized applications.

Competitive Landscape

ArcScan competes in the ophthalmic diagnostic imaging market, which is dominated by optical technologies like OCT from companies such as Zeiss, Heidelberg, and Optovue. Its primary differentiation is imaging behind the iris, where OCT cannot penetrate. For ICL sizing, it competes with older, less precise ultrasound biometers and empirical sizing methods. It holds a unique, patent-protected position in robotic VHF-US for the anterior segment.

More companies in Diagnostics & Precision Medicine →More companies in United States →